Literature DB >> 21989341

Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?

Matthias Dettmer1, Anja Schmitt, Hans Steinert, Andreas Haldemann, Andreas Meili, Holger Moch, Paul Komminoth, Aurel Perren.   

Abstract

BACKGROUND: Poorly differentiated (PD) carcinomas of the thyroid are conceptually situated between well-differentiated (papillary or follicular) carcinomas and anaplastic thyroid carcinomas. Although the morphologic criteria for PD tumors are well defined, it is not clear how much of a PD area besides a well-differentiated component in a given tumor is required to allow such a diagnosis.
METHODS: We identified 42 patients suffering from thyroid carcinoma with an adverse clinical outcome. Fifty patients with follicular carcinoma were added as controls. We analyzed poorly differentiated areas by applying the Turin criteria of PD carcinomas. These criteria consisted of the presence of a solid/trabecular/insular growth pattern, lack of nuclear features of papillary carcinoma, and presence of 1 of the following features: (1) convoluted nuclei, (2) tumor necrosis, (3) 3 or more mitoses per 10 high-power fields.
RESULTS: Using a cutoff value of 10% of PD areas per examined tumor surface, we identified a total of 35 PD carcinomas. Despite using a threshold of 10% of the tumor area as poorly differentiated, the survival data in a Kaplan-Meier analysis were significantly worse than those in the control group (P<0.001) and did not differ from tumors with a PD area >50%. In a multivariate analysis that included age, sex, tumor stage, and PD area >10% against survival data, the only consistent significant factor was PD differentiation (P<0.001).
CONCLUSIONS: As even slight amounts of PD areas (≥ 10%) in a thyroid carcinoma affect the prognosis significantly, the presence of such areas may be worth reporting in thyroid carcinomas.

Entities:  

Mesh:

Year:  2011        PMID: 21989341     DOI: 10.1097/PAS.0b013e31822cf962

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

1.  MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.

Authors:  Matthias S Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  J Mol Endocrinol       Date:  2014-03-06       Impact factor: 5.098

2.  Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.

Authors:  Junko Akaishi; Tetsuo Kondo; Kiminori Sugino; Yuna Ogimi; Chie Masaki; Kiyomi Y Hames; Tomonori Yabuta; Chisato Tomoda; Akifumi Suzuki; Kenichi Matsuzu; Takashi Uruno; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Ryohei Katoh; Koichi Ito
Journal:  World J Surg       Date:  2019-09       Impact factor: 3.352

Review 3.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

4.  PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma.

Authors:  Matthew W Rosenbaum; Benjamin J Gigliotti; Sara I Pai; Sareh Parangi; Heather Wachtel; Mari Mino-Kenudson; Viswanath Gunda; William C Faquin
Journal:  Endocr Pathol       Date:  2018-03       Impact factor: 3.943

5.  Poorly differentiated thyroid carcinoma: an incubating entity.

Authors:  Peter M Sadow; William C Faquin
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-21       Impact factor: 5.555

6.  Poorly Differentiated Thyroid Carcinoma Arising in Struma Ovarii.

Authors:  Surapan Khunamornpong; Jongkolnee Settakorn; Kornkanok Sukpan; Prapaporn Suprasert; Sumalee Siriaunkgul
Journal:  Case Rep Pathol       Date:  2015-06-21

7.  Atypical Features Resembling Poorly Differentiated Thyroid Carcinoma Presenting Entirely within a Follicular Adenoma.

Authors:  Daniel Ching; Connull Leslie
Journal:  Case Rep Pathol       Date:  2018-07-18

Review 8.  Poorly differentiated thyroid carcinoma : An underdiagnosed entity.

Authors:  M S Dettmer; A Schmitt; P Komminoth; A Perren
Journal:  Pathologe       Date:  2020-06       Impact factor: 1.011

9.  Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.

Authors:  Agnieszka Walczyk; Janusz Kopczyński; Danuta Gąsior-Perczak; Iwona Pałyga; Artur Kowalik; Magdalena Chrapek; Maria Hejnold; Stanisław Góźdź; Aldona Kowalska
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

10.  PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study.

Authors:  Soledad Cameselle-García; Sámer Abdulkader-Sande; María Sánchez-Ares; Gemma Rodríguez-Carnero; Jesús Garcia-Gómez; Francisco Gude-Sampedro; Ihab Abdulkader-Nallib; José Manuel Cameselle-Teijeiro
Journal:  Oncol Lett       Date:  2021-05-24       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.